|
EP400 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.622500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.869500E-02 |
| Normal-vs-Stage2 |
1.058770E-01 |
| Normal-vs-Stage3 |
1.195410E-03 |
| Normal-vs-Stage4 |
1.513790E-02 |
| Stage1-vs-Stage2 |
8.888000E-01 |
| Stage1-vs-Stage3 |
7.106400E-02 |
| Stage1-vs-Stage4 |
4.457200E-01 |
| Stage2-vs-Stage3 |
2.797600E-01 |
| Stage2-vs-Stage4 |
6.818000E-01 |
| Stage3-vs-Stage4 |
4.885000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.499700E-03 |
| Normal-vs-AfricanAmerican |
2.843600E-01 |
| Normal-vs-Asian |
2.538800E-01 |
| Caucasian-vs-AfricanAmerican |
5.781600E-01 |
| Caucasian-vs-Asian |
2.073800E-01 |
| AfricanAmerican-vs-Asian |
8.575800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.463500E-02 |
| Normal-vs-Female |
4.118700E-03 |
| Male-vs-Female |
5.727800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.842200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.672260E-02 |
| Normal-vs-Age(61-80Yrs) |
8.216900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.633900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.171800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.491600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.055400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.675600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.036800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.306800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.171800E-04 |
| Classical-VS-Follicular |
2.077900E-02 |
| Classical-VS-Other |
2.646400E-01 |
| Classical-VS-Normal |
2.118200E-01 |
| Tall-VS-Follicular |
2.905800E-01 |
| Tall-VS-Other |
5.303200E-01 |
| Tall-VS-Normal |
6.14249999999483E-05 |
| Follicular-VS-Other |
9.798400E-01 |
| Follicular-VS-Normal |
4.176100E-03 |
| Other-VS-Normal |
8.548500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.200500E-03 |
| Normal-vs-N1 |
4.735500E-03 |
| N0-vs-N1 |
6.300600E-01 |
|
|
